Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi.
Roche
B
B
Rozenberg
S
S
Cambau
E
E
Desplaces
N
N
Dion
E
E
Dubourg
G
G
Koeger
A C
AC
Robin
H
H
Vergeron
H
H
Bourgeois
P
P
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use*; D015299:Discitis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D024841:Fluoroquinolones; D006801:Humans; D008159:Lumbar Vertebrae; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000188:drug therapy*; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification*; D015363:Quinolones / Q000627:therapeutic use*; D012447:Sacrum
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D017291:Clarithromycin; C061363:sparfloxacin